logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Xintai Medical (02291.HK) spent HKD 313,600 to repurchase 27,000 shares on September 25.

date
25/09/2026
Zhitong Finance APP News, Xintai Medical (02291.HK) announced that on September 25, 2026, it spent HK$313,600 to repurchase 27,000 shares.
Latest
1 m ago
KEEP (03650.HK) repurchased 84,800 shares for HK$105,700 on September 25.
1 m ago
Deutsche Bank: Raises Meta's price target from $750 to $820.
8 m ago
Pagoda Group (02411.HK) repurchased 360,000 shares for HK$538,000 on September 25.
10 m ago
Champion Technology Group (00092.HK) issues a profit warning, expecting an annual loss attributable to shareholders of approximately HK$81 million to approximately HK$87 million.
10 m ago
BASF in Ludwigshafen, Germany, recently proposed a merger to Evonik and its largest shareholder.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.